Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.93 USD | -0.25% | +1.81% | +11.97% |
Apr. 25 | Transcript : Aldeyra Therapeutics, Inc. - Special Call | |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Business Summary
Number of employees: 10
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 05-08-31 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 21-12-31 |
Kelly Mizer
PRN | Corporate Officer/Principal | - | 21-09-30 |
Stephen Machatha
PRN | Corporate Officer/Principal | 47 | 20-12-31 |
James A. Gow
PRN | Corporate Officer/Principal | - | 20-03-11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 09-04-30 |
Martin Joyce
BRD | Director/Board Member | 70 | 13-09-30 |
Ben Bronstein
BRD | Director/Board Member | 74 | 10-05-31 |
Todd Brady
CEO | Chief Executive Officer | 52 | 05-08-31 |
Neal Walker
BRD | Director/Board Member | 54 | 13-05-31 |
Richard Douglas
CHM | Chairman | 71 | 16-09-12 |
Director/Board Member | 65 | 20-01-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 59,414,489 | 48,953,902 ( 82.39 %) | 0 | 82.39 % |
Company contact information
Aldeyra Therapeutics, Inc.
131 Hartwell Avenue Suite 320
02421, Lexington
+781 761 4904
http://www.aldeyra.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.97% | 233M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ALDX Stock
- Company Aldeyra Therapeutics, Inc.